Crestchem

Which are the latest news on Crestchem?

Why is Crestchem Ltd falling/rising?

As of 05-Sep, Crestchem Ltd's stock price is rising to 131.75, reflecting a 1.35% increase. The stock shows strong performance indicators, trading above key moving averages and outperforming its sector, despite a decline in investor participation.

As of 05-Sep, Crestchem Ltd's stock price is rising, currently at 131.75, reflecting a change of 1.75 or 1.35% increase. This upward movement is supported by several factors. Firstly, the stock opened with a gain of 4.23% today and reached an intraday high of Rs 136, indicating strong initial investor interest. Additionally, Crestchem has outperformed its sector by 2.81%, suggesting that it is performing better than its peers in the market.<BR><BR>Moreover, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically indicates a bullish trend. Over the past month, Crestchem has shown a significant increase of 7.29%, contrasting with a decline in the benchmark Sensex by 2.44%. Year-to-date, the stock has risen by 17.16%, while the Sensex has fallen by 10.21%, further highlighting its strong performance relative to the market.<BR><BR>However, it is important to note that there has been a decline in investor participation, with delivery volume dropping by 72.19% against the 5-day average. Despite this, the overall positive performance metrics and the stock's ability to maintain higher trading levels suggest that Crestchem Ltd is currently experiencing a rise in its stock price.

Should I buy, sell or hold Crestchem Ltd?

Who are in the management team of Crestchem?

The management team of Crestchem includes Dipak N Patel (Chairman & Managing Director), Khyati Dipakkumar Vyas (CFO & Company Secretary), and several independent directors: Rajesh I Mody, Binaben Parasbhai Patel, Nitin Shantilal Shah, and Manojkumar Babubhai Patel, along with Executive Director Nirmit Dipak Patel. They are responsible for the company's strategic direction and operations.

The management team of Crestchem includes the following individuals:<BR><BR>1. **Dipak N Patel** - Chairman & Managing Director<BR>2. **Rajesh I Mody** - Non-Executive & Independent Director<BR>3. **Binaben Parasbhai Patel** - Non-Executive & Independent Director<BR>4. **Nitin Shantilal Shah** - Non-Executive & Independent Director<BR>5. **Khyati Dipakkumar Vyas** - CFO & Company Secretary<BR>6. **Manojkumar Babubhai Patel** - Independent Director<BR>7. **Nirmit Dipak Patel** - Executive Director<BR><BR>This team is responsible for guiding the company's strategic direction and overseeing its operations.

What does Crestchem do?

Crestchem Ltd manufactures Nutrition Chemical Products in the Specialty Chemicals industry and is classified as a Micro Cap company, with net sales of 9 Cr and a net profit of 1 Cr as of June 2026. The company has a market cap of INR 41 Cr and key metrics include a P/E ratio of 11.00 and a dividend yield of 1.14%.

Overview: <BR>Crestchem Ltd is engaged in the manufacturing of Nutrition Chemical Products within the Specialty Chemicals industry and operates as a Micro Cap company.<BR><BR>History: <BR>Crestchem Limited was incorporated in April 1991. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 9 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 1 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 41 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 11.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 1.14% <BR>Debt Equity: -0.04 <BR>Return on Equity: 33.79% <BR>Price to Book: 4.01<BR><BR>Contact Details: <BR>Address: Sr No 550/1 Sub Plot No 12, Village-Indrad Taluka Kadi Mehsana Gujarat : 382715 <BR>Tel: 91-2764-278247/09409119484 <BR>Email: info@crestchemlimited.in/investor@c <BR>Website: http://www.crestchemlimited.in

Who are the peers of the Crestchem?

Crestchem's peers include Eiko Lifescience, Alkali Metals, KKalpana Inds., Kemistar Corp., Hardcast.& Waud, Bhatia Colour, Yug Decor, Seya Industries, and Dynamic Industri. Among these, Hardcast.& Waud shows the highest 1-year return at 11.35%, while KKalpana Inds. has the lowest at -47.46%, with Crestchem's return at 6.10%.

Peers: Eiko Lifescience, Alkali Metals, KKalpana Inds., Kemistar Corp., Hardcast.& Waud, Bhatia Colour, Yug Decor, Seya Industries, Dynamic Industri.<BR><BR>Quality Snapshot: Excellent management risk is observed at Eiko Lifescience and Hardcast.& Waud, while Average management risk is found at Kemistar Corp., Yug Decor, and Dynamic Industri. Below Average management risk is present at Alkali Metals, KKalpana Inds., Bhatia Colour, Seya Industries, and Daikaffil Chem. Excellent growth is noted at Eiko Lifescience and Hardcast.& Waud, while Good growth is seen at Crestchem. Below Average growth is reported for Alkali Metals, KKalpana Inds., Kemistar Corp., Bhatia Colour, Yug Decor, Seya Industries, and Dynamic Industri. Average capital structure is found at Kemistar Corp. and Yug Decor, while Good capital structure is noted at Hardcast.& Waud, Bhatia Colour, and Crestchem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Hardcast.& Waud at 11.35%, while KKalpana Inds. has the lowest at -47.46%. Crestchem's 1-year return of 6.10% is higher than KKalpana Inds. but lower than Hardcast.& Waud. Additionally, the six-month returns for KKalpana Inds., Seya Industries, and Daikaffil Chem are negative.

How big is Crestchem?

As of 31st August, Crestchem Ltd has a market capitalization of 41.00 Cr, with recent Net Sales of 19.49 Cr and a Net Profit of 2.04 Cr. As of March 2026, Shareholder's Funds were 9.89 Cr and Total Assets were 16.21 Cr.

As of 31st August, Crestchem Ltd has a market capitalization of 41.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest two quarters, Crestchem reported Net Sales of 19.49 Cr and a Net Profit of 2.04 Cr. This reflects the company's performance over the most recent periods.<BR><BR>The latest reporting period for the balance sheet is March 2026, where Shareholder's Funds amounted to 9.89 Cr and Total Assets were valued at 16.21 Cr.

Are Crestchem Ltd latest results good or bad?

Crestchem Ltd's latest quarterly results are strong, with record highs in net profit and operating margin; however, annual revenues declined by 19%, and the stock has underperformed significantly, indicating potential underlying issues. Investors should weigh these mixed signals carefully.

Crestchem Ltd's latest results present a mixed picture. On one hand, the company achieved record highs in quarterly net profit and operating margin for the March 2026 quarter, with net profit reaching ₹1.10 crores and an operating margin of 13.78%. These figures indicate strong operational performance and improved efficiency.<BR><BR>However, when looking at the broader financial context, the annual results for FY25 show a decline in revenues to ₹25.00 crores, down 19% year-on-year, which raises concerns about the sustainability of the recent quarterly success. The flat net profit for the full year compared to FY24 further complicates the narrative, suggesting volatility in the company's earnings.<BR><BR>Additionally, the stock has underperformed significantly over the past year, with a return of -31.87%, compared to the Sensex's decline of -8.40%. This underperformance reflects a loss of investor confidence and highlights the challenges the company faces.<BR><BR>In summary, while the latest quarterly results are strong, the overall annual performance and stock trends indicate underlying issues that investors should carefully consider.

When is the next results date for Crestchem Ltd?

The next results date for Crestchem Ltd is 29 May 2026.

The next results date for Crestchem Ltd is scheduled for 29 May 2026.

Is Crestchem overvalued or undervalued?

As of November 19, 2025, Crestchem is fairly valued with a PE ratio of 17.38 and has underperformed the Sensex with a year-to-date return of -58.22%, making it less attractive compared to peers like Godrej Industries and Solar Industries.

As of 19 November 2025, Crestchem's valuation grade has moved from very attractive to fair, indicating a shift in its market perception. The company is currently fairly valued, with a PE ratio of 17.38, an EV to EBITDA of 15.34, and a ROE of 25.03%. In comparison, peers such as Godrej Industries, which is rated attractive, has a significantly higher PE ratio of 37.28, while Solar Industries is deemed very expensive with a PE of 94.38.<BR><BR>Despite the fair valuation, Crestchem has underperformed relative to the Sensex, with a year-to-date return of -58.22% compared to the Sensex's 9.02%. This underperformance, coupled with its current ratios, suggests that while Crestchem may not be undervalued, it is not positioned as a strong investment compared to its peers in the specialty chemicals sector.

How has been the historical performance of Crestchem?

Crestchem has shown significant growth in net sales and profitability, with net sales increasing from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25, and profit after tax rising from 0.57 Cr to 2.73 Cr during the same period. The company's financial performance reflects strong operational efficiency and enhanced shareholder value.

Answer:<BR>The historical performance of Crestchem shows a significant upward trend in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Crestchem's net sales have increased from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25, reflecting a strong growth trajectory. The total operating income followed a similar pattern, rising from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25. The raw material costs also increased, from 5.82 Cr in Mar'21 to 18.76 Cr in Mar'25, indicating higher production expenses. Operating profit, excluding other income, improved from 0.65 Cr in Mar'21 to 3.28 Cr in Mar'25, while the overall operating profit rose from 0.70 Cr to 3.72 Cr during the same period. Profit before tax showed a notable increase from 0.67 Cr in Mar'21 to 3.66 Cr in Mar'25, leading to a profit after tax of 2.73 Cr in Mar'25, up from 0.57 Cr in Mar'21. The earnings per share also grew significantly from 1.9 in Mar'21 to 9.1 in Mar'25. On the balance sheet, total assets increased from 3.00 Cr in Mar'21 to 10.52 Cr in Mar'25, while total liabilities rose from 3.00 Cr to 10.52 Cr, with no long-term borrowings reported. The book value per share improved from 4.97 in Mar'21 to 24.92 in Mar'25, indicating enhanced shareholder value. Cash flow from operating activities turned positive in Mar'24 at 1.00 Cr and remained steady in Mar'25, showcasing improved operational efficiency. Overall, Crestchem's financial performance demonstrates robust growth and profitability over the years.

Who are the top shareholders of the Crestchem?

The top shareholder of Crestchem is Mr. Dipak Narendraprasad Patel, with a 28.94% stake. Individual investors hold 66.63% of the shares, with no institutional holdings or pledged promoter shares.

The top shareholders of Crestchem include Mr. Dipak Narendraprasad Patel, who holds the highest promoter stake at 28.94%. Additionally, individual investors collectively hold a significant portion of the company, accounting for 66.63% of the shareholding. There are no institutional holdings from mutual funds or foreign institutional investors, and there are no pledged promoter holdings.

What is the technical trend for Crestchem?

As of June 2, 2025, Crestchem's technical trend has shifted to bearish, supported by a weak weekly MACD, bearish Bollinger Bands, and significant recent declines of -9.24% over one week and -15.63% over one month, despite a contrasting bullish monthly KST.

As of 2 June 2025, the technical trend for Crestchem has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. The weekly MACD is bearish, and Bollinger Bands are also signaling bearish conditions. Daily moving averages confirm the bearish trend. While the monthly KST is bullish, it contrasts with the bearish signals from other indicators. The stock has seen significant declines recently, with a 1-week return of -9.24% and a 1-month return of -15.63%, further supporting the bearish outlook.

Has Crestchem declared dividend?

Crestchem Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of August 23, 2024. The dividend yield is 0.3%, and while the company has shown significant price appreciation over the years, the total returns vary across different periods.

Crestchem Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 23 Aug 24<BR><BR>Dividend Yield: 0.3%.<BR><BR>Total Returns by Period:<BR>Over the 6-month period, Crestchem experienced a price return of -39.7%, with no dividend return, resulting in a total return of -39.7%.<BR><BR>In the 1-year period, the price return was 26.84%, with a dividend return of 0.37%, leading to a total return of 27.21%.<BR><BR>For the 2-year period, the price return was 84.46%, with a dividend return of 0.68%, resulting in a total return of 85.14%.<BR><BR>During the 3-year period, the price return was 243.46%, with a dividend return of 1.12%, culminating in a total return of 244.58%.<BR><BR>In the 4-year period, the price return was 328.42%, with a dividend return of 1.10%, leading to a total return of 329.52%.<BR><BR>Over the 5-year period, Crestchem saw a remarkable price return of 1450.48%, with a dividend return of 4.76%, resulting in a total return of 1455.24%.<BR><BR>Overall, Crestchem has declared a dividend while also showing varying total returns over different periods, with significant growth in price returns, particularly over the longer term. The dividend yield remains relatively low compared to the substantial price appreciation.